Priyankar Pal

ORCID: 0000-0003-3273-6218
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Kawasaki Disease and Coronary Complications
  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Coronary Artery Anomalies
  • Systemic Lupus Erythematosus Research
  • Renal Diseases and Glomerulopathies
  • Immunodeficiency and Autoimmune Disorders
  • Vasculitis and related conditions
  • Inflammasome and immune disorders
  • Parvovirus B19 Infection Studies
  • Mechanical Circulatory Support Devices
  • Immune Cell Function and Interaction
  • Cardiac Structural Anomalies and Repair
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Family and Disability Support Research
  • Eosinophilic Disorders and Syndromes
  • Antifungal resistance and susceptibility
  • Vascular Tumors and Angiosarcomas
  • Nail Diseases and Treatments
  • Drug-Induced Adverse Reactions
  • Streptococcal Infections and Treatments
  • Tuberculosis Research and Epidemiology
  • Blood Coagulation and Thrombosis Mechanisms
  • Inflammatory Myopathies and Dermatomyositis

Institute of Child Health
2016-2025

Apollo Gleneagles Hospitals
2024

Apollo Hospitals
2022

Fortis Hospital
2021

Bristol Royal Hospital for Children
2014

To describe the clinical, laboratory, and histopathologic features, current treatment, outcome of patients with macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (JIA).In this multinational, multicenter study, pediatric rheumatologists hemato-oncologists entered patient data collected retrospectively into a web-based database.A total 362 patients, 22% whom had MAS at onset JIA, were included in study by 95 investigators from 33 countries. The most...

10.1002/art.38802 article EN Arthritis & Rheumatology 2014-07-30

To develop a composite disease activity score for systemic JIA (sJIA) and to provide preliminary evidence of its validity.The Juvenile Arthritis Disease Activity Score (sJADAS) was constructed by adding the four items original JADAS fifth item that aimed quantify features. Validation analyses were conducted on patients with definite or probable/possible sJIA enrolled at first visit time flare, who had active manifestations, which should include fever. Patients reassessed 2 weeks 3 months...

10.1093/rheumatology/keaa240 article EN Lara D. Veeken 2020-04-15
Francesca Minoia Francesca Bovis Sergio Davì Antonella Insalaco Kai Lehmberg and 95 more Susan Shenoi Sheila Weitzman Graciela Espada Yijin Gao Jordi Antón Toshiyuki Kitoh Özgür Kasapçopur Helga Sanner Rosa Merino Itziar Astigarraga Maria Alessio Michael Jeng Vyacheslav Chasnyk Kim E. Nichols Huasong Zeng Caifeng Li Concetta Micalizzi Nicolino Ruperto Alberto Martini Randy Q. Cron Angelo Ravelli AnnaCarin Horne Mario Abinun Amita Aggarwal Jonathan Akikusa Sulaiman M. Al‐Mayouf Maria Alessio Jordi Antón María Teresa Apaz Itziar Astigarraga Tadej Avčin Nuray Aktay Ayaz Patrizia Barone Bianca Bica Isabel Bolt Francesca Bovis Luciana Breda Vyacheslav Chasnyk Rolando Cimaz Fabrizia Corona Randy Q. Cron Rubén Cuttica Sergio Davì Zane Dāvidsone Carmen De Cunto Jaime de Inocencio Arocena Erkan Demirkaya Eli M. Eisenstein Sandra Enciso Graciela Espada Michel Fischbach Michael Frosch Romina Gallizzi María Luz Gámir Gámir Yijin Gao Thomas A. Griffin Alexei A. Grom Soad Hashad Teresa Hennon Jan‐Inge Henter AnnaCarin Horne Gerd Horneff Huasong Zeng Adam M. Huber Norman T. Ilowite Antonella Insalaco Maka Ioseliani Michael Jeng Agneza Marija Kapović Özgür Kasapçopur Raju Khubchandani Toshiyuki Kitoh Isabelle Koné‐Paut Sheila Knupp Feitosa de Oliveira Bianca Lattanzi Kai Lehmberg Loredana Lepore Caifeng Li Jeffrey M. Lipton Silvia Magni‐Manzoni Despoina Maritsi Alberto Martini Deborah McCurdy Rosa Merino Concetta Micalizzi Paivi Miettunen Francesca Minoia Velma Mulaosmanović Kim E. Nichols Susan Searles Nielsen Seza Özen Priyankar Pal Sampath Prahalad Angelo Ravelli Donato Rigante

10.1016/j.jpeds.2017.06.005 article EN The Journal of Pediatrics 2017-08-14

Abstract Background Post‐COVID multisystem hyperinflammatory syndrome in children (MISC) has clinical and laboratory similarities with Kawasaki disease (KD). Inflammatory markers like C‐reactive protein (CRP), interleukin 6 (IL6) as well N‐terminal probrain natriuretic peptide (NT‐proBNP) are elevated both. This study attempts a comparative analysis of the 3 an attempt at early differentiation for planning appropriate management. Methodology analytical conducted Institute Child Health,...

10.1111/1756-185x.14236 article EN International Journal of Rheumatic Diseases 2021-11-08

A term infant girl with uneventful antenatal history had an erythematous rash followed by fever from day 8. She was diagnosed late-onset sepsis and treated accordingly. received immunoglobulin for persistent thrombocytopenia, after which there transient improvement. The patient transferred to our hospital on 25 recurrence of fever, watery diarrhea, a generalized maculopapular rash. On admission, she tachycardia, tachypnoea, anemia, hypoalbuminemia, edema. Reverse transcriptase-polymerase...

10.1542/peds.2020-042093 article EN PEDIATRICS 2021-08-25

Abstract Background: While classical Kawasaki disease (KD) is easily diagnosed by a well-established set of diagnostic criteria, the diagnosis incomplete KD remains elusive. Clinical Description: A 1-year-old girl presented with high fever, painful swelling, and redness over anterior part neck, associated swallowing difficulty. There was no rash, eyes, or lymphadenopathy. Management Outcome: Considering cellulitis antibiotics were initiated. She developed stridor received dexamethasone....

10.4103/ipcares.ipcares_131_24 article EN cc-by-nc-sa Indian Pediatrics Case Reports 2025-01-01

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome reflects a serious hypersensitivity reaction to drugs, is characterized by skin rash, fever, lymph node enlargement, internal organ involvement. So far, numerous drugs such as sulfonamides, phenobarbital, sulfasalazine, carbamazepine, phenytoin have been reported cause DRESS syndrome. We report case of 10-year-old girl who developed clinical manifestations lymphadenopathy, hypereosinophilia, visceral involvement (hepatitis...

10.4103/0019-5154.91850 article EN cc-by-nc-sa Indian Journal of Dermatology 2011-01-01

We present clinical, biochemical, and histopathological characteristics treatment outcomes of biopsy proven childhood lupus nephritis (LN) from a low/middle income setting treated in the current era increased use Mycophenolate Mofetil (MMF) biologics.Retrospective observational study children (1-18 years) with LN 01.01.2010 to 31.01.2020.60 met our inclusion criteria (80%, n = 48 were females). The median age at diagnosis was 11 (IQR: 9-12) years. most common extra-renal manifestation...

10.1177/09612033231202843 article EN Lupus 2023-09-14

Abstract Drug rash, eosinophilia, and systemic symptoms ( DRESS ) syndrome is a severe hypersensitivity reaction that usually occurs within 6 weeks of exposure to the offending drug. Diagnosis straightforward in patients with pyrexia, skin hepatitis, eosinophilia preceding history agents often associated syndrome, such as aromatic anticonvulsants sulfa drugs, but diagnosis may still be challenge. We report 4‐year‐old child probable complicated by multiple hematologic complications developed...

10.1111/pde.13131 article EN Pediatric Dermatology 2017-05-01

Macrophage activation syndrome (MAS) is a dreaded complication of systemic inflammatory diseases and most commonly seen in juvenile idiopathic arthritis (sJIA). We evaluate the clinical features, laboratory findings outcomes pediatric MAS, assess response to different pharmacological therapies, finally identify possible factors associated with an unfavorable outcome.This retrospective analysis data from patients diagnosed as having admitted between July 2008 April 2018 into Department...

10.1111/1756-185x.13915 article EN International Journal of Rheumatic Diseases 2020-07-14
Coming Soon ...